Monoclonal Mouse anti‑Human Herpesvirus 8 HHV‑8 ORF45 Antibody (clone 2D4A5, IHC, WB) LS‑C41378
Monoclonal Mouse anti‑Human Herpesvirus 8 HHV‑8 ORF45 Antibody (clone 2D4A5, IHC, WB) LS‑C41378
Antibody:
HHV-8 ORF45 Mouse anti-Human Herpesvirus 8 Monoclonal (2D4A5) Antibody
Application:
IHC, ICC, WB, ELISA
Reactivity:
Human Herpesvirus 8
Format:
Unconjugated, Unmodified
Overview
Antibody:
HHV-8 ORF45 Mouse anti-Human Herpesvirus 8 Monoclonal (2D4A5) Antibody
Application:
IHC, ICC, WB, ELISA
Reactivity:
Human Herpesvirus 8
Format:
Unconjugated, Unmodified
Specifications
Description
HHV-8 ORF45 antibody LS-C41378 is an unconjugated mouse monoclonal antibody to human herpesvirus 8 HHV-8 ORF45. Validated for ELISA, ICC, IHC and WB.
Target
Human Herpesvirus 8 HHV-8 ORF45
Reactivity
Human Herpesvirus 8
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Immunogen
Purified recombinant fragment of KSHV ORF45 expressed in E. Coli.
Applications
- IHC
- ICC
- Western blot (1:100 - 1:500)
- ELISA (1:10000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
Ascitic fluid, 0.03% sodium azide
Storage
Short term: store at 4°C. Long term: store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Virus
Applications:
IHC, Western blot
Species:
Human Herpesvirus 8
Applications:
Western blot, ELISA
Reactivity:
Human
Range:
3.12-200 ng/ml
Reactivity:
Human
Range:
123.5-10000 pg/ml
Species:
Pig, Human
Applications:
ICC, Western blot, Immunoprecipitation
Reactivity:
Human
Range:
0.31-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/19/2024